alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › devices

devices

4 studies tagged devices, dated 2016-05-31 to 2024-10-23. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. Smartphone automated motor and speech analysis for early detection of Alzheimer's disease and Parkinson's disease: Validation of TapTalk across 20 different devices 2024-10-23
  2. A digital teleneuropsychology platform for the diagnosis of mild cognitive impairment: from concept to certification as a medical device 2024-02-21
  3. Targeted delivery of nerve growth factor to the cholinergic basal forebrain of Alzheimer's disease patients: application of a second-generation encapsulated cell biodelivery device 2016-07-07

Studies

4 studies carry this tag.

Date range

2016 to 2024

Top journals

  • Alzheimer's & dementia (Amsterdam, Netherlands) 1
  • Alzheimer's research & therapy 1
  • Journal of neurovirology 1
  • Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Smartphone automated motor and speech analysis for early detection of Alzheimer's disease and Parkinson's disease: Validation of TapTalk across 20 different devices

    ✓ Peer-reviewed alzhub usefulness score 52 out of 100. Alzheimer's & dementia (Amsterdam, Netherlands) 2024-10-23 Cognitive tests and assessment

    Validation of TapTalk across a range of devices is an important step in the development of smartphone-based telemedicine and was achieved in this study.

  2. A digital teleneuropsychology platform for the diagnosis of mild cognitive impairment: from concept to certification as a medical device

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2024-02-21 Cognitive tests and assessment

    Neuropsychology services will benefit from the implementation in clinics of harmonized digital tools with adequate scientific and technological standards.

  3. Targeted delivery of nerve growth factor to the cholinergic basal forebrain of Alzheimer's disease patients: application of a second-generation encapsulated cell biodelivery device

    ✓ Peer-reviewed alzhub usefulness score 48 out of 100. Alzheimer's research & therapy 2016-07-07 Biomarkers

    The data derived from this patient cohort demonstrate the safety and tolerability of sustained NGF release by a second-generation NGF-ECB implant to the basal forebrain, with uneventful surgical implant and removal of NGF-ECB implants in a new dosing cohort of four patients with AD.

  4. Preliminary study of a novel cognitive assessment device for the evaluation of HIV-associated neurocognitive impairment

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Journal of neurovirology 2016-05-31 Cognitive tests and assessment

    Given the high prevalence of HIV-associated neurocognitive disorders (HAND), we examined the performance of a novel computerized cognitive assessment device (NCAD) for the evaluation of neurocognitive impairment in the setting of HIV.

All topic tags with their study counts